BAGSVAERD, DENMARK--(Marketwire - October 01, 2012) - In continuation of the company's
announcements dated 2 May 2012 and 9 August 2012 concerning planned share
repurchase programmes, and pursuant to Section 204.25 of the New York Stock
Exchange Listed Company Manual, this is to report that Novo Nordisk A/S
(NYSE: NVO) and its wholly-owned affiliates on 30 September 2012 owned
16,374,105 of its own B shares of DKK 1, corresponding to a total nominal
value of DKK 16,374,105 or 2.9% of the total share capital.
Company Announcement No 62 2012:
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Novo Nordisk A/S via Thomson Reuters ONE